{
    "clinical_study": {
        "@rank": "33416", 
        "acronym": "N30-005", 
        "arm_group": {
            "arm_group_label": "Brisdelle (paroxetine mesylate)", 
            "arm_group_type": "Experimental", 
            "description": "Brisdelle (paroxetine mesylate) Capsules taken orally with 240 mL of water for 20 days."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the pharmacokinetics (absorption, breakdown and\n      elimination from the body), safety and tolerability of Brisdelle (paroxetine mesylate)\n      Capsules 7.5 mg when given as a single dose and multiple doses."
        }, 
        "brief_title": "Pharmacokinetic Evaluation of Brisdelle\u2122 (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Brisdelle (paroxetine mesylate) Capsules\nAll subjects will receive Brisdelle (paroxetine mesylate) capsules, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                        "title": "Brisdelle (Paroxetine Mesylate) Capsules"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "24"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "4"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "7.29", 
                                            "@value": "56.2"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "24"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "24"
                                        }
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "24"
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "166.19", 
                                                        "@value": "86.95"
                                                    }
                                                }, 
                                                "sub_title": "AUC0-last (Hour x ng/mL)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "189.88", 
                                                        "@value": "78.80"
                                                    }
                                                }, 
                                                "sub_title": "AUC0-inf (Hour x ng/mL)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "51.83", 
                                                        "@value": "38.90"
                                                    }
                                                }, 
                                                "sub_title": "AUC0-24 (Hour x ng/mL)"
                                            }
                                        ]
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "AUC (Hour*ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Hour*ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "AUC (Hour*ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "3.38", 
                                                    "@value": "2.77"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmax (ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "Cmax (ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "0.01", 
                                                    "@value": "0.05"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Kel (Hour^-1) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Hour^(-1)"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "Kel (Hour^-1) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "11.45", 
                                                    "@value": "17.30"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Mean t1/2 Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Hours"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "Mean t1/2 Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "1.00", 
                                                    "@upper_limit": "8.00", 
                                                    "@value": "6.00"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Median t1/2 Single Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1", 
                        "title": "Median t1/2 Single Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "222.65", 
                                                        "@value": "237.34"
                                                    }
                                                }, 
                                                "sub_title": "AUC0-last (Hour x ng/mL)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "222.64", 
                                                        "@value": "237.28"
                                                    }
                                                }, 
                                                "sub_title": "AUC0-24 (Hour x ng/mL)"
                                            }
                                        ]
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "AUC (Hour*ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Hour*ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "AUC (Hour*ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "11.92", 
                                                    "@value": "13.10"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmax (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Cmax (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "7.57", 
                                                    "@value": "7.67"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cmin (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Cmin (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "3.00", 
                                                    "@upper_limit": "8.00", 
                                                    "@value": "6.00"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Mean", 
                                    "title": "Tmax (Hour) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Hours"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Tmax (Hour) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Accumulation Index is the ratio of AUC 0-24 after multiple doses versus a single dose. It is the increase in drug plasma concentration after multiple dosing until a steady state is reached.  In this case the steady state Accumulation Index was calculated at Day 19. Accumulation Index is calculated at the end of the dosing period.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "0.12", 
                                                    "@upper_limit": "23.48", 
                                                    "@value": "9.71"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Accumulation Index is the ratio of AUC 0-24 after multiple doses versus a single dose. It is the increase in drug plasma concentration after multiple dosing until a steady state is reached.  In this case the steady state Accumulation Index was calculated at Day 19. Accumulation Index is calculated at the end of the dosing period.", 
                                    "dispersion": "Full Range", 
                                    "param": "Mean", 
                                    "title": "Accumulation Index Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg at Day 19", 
                                    "units": "Ratio"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Accumulation Index Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg at Day 19", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Fluctuation Index is (Cmax-Cmin)/Cavg,ss. It is peak trough fluctuation within one dosing interval at steady state.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "35.57", 
                                                    "@upper_limit": "153.20", 
                                                    "@value": "75.76"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Fluctuation Index is (Cmax-Cmin)/Cavg,ss. It is peak trough fluctuation within one dosing interval at steady state.", 
                                    "dispersion": "Full Range", 
                                    "param": "Mean", 
                                    "title": "Fluctuation Index (%) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "Percentage of steady state concentration"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Fluctuation Index (%) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "9.28", 
                                                    "@value": "9.89"
                                                }
                                            }
                                        }
                                    }, 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Cavg,ss (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Cavg,ss (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "C(t) is the measured plasma level \"Concentration\" of the drug at \"time = t\" expressed as nanograms per milliliter.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                                "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "24"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "9.17", 
                                                        "@value": "8.53"
                                                    }
                                                }, 
                                                "sub_title": "C\u03c418 (ng/mL)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "8.49", 
                                                        "@value": "8.35"
                                                    }
                                                }, 
                                                "sub_title": "C\u03c419 (ng/mL)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "9.19", 
                                                        "@value": "8.79"
                                                    }
                                                }, 
                                                "sub_title": "C\u03c420 (ng/mL)"
                                            }
                                        ]
                                    }, 
                                    "description": "C(t) is the measured plasma level \"Concentration\" of the drug at \"time = t\" expressed as nanograms per milliliter.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Ct (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                                    "units": "ng/mL"
                                }
                            ]
                        }, 
                        "population": "Safety and evaluable pharmacokinetic populations = 24 randomized subjects.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 19", 
                        "title": "Ct (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Brisdelle (paroxetine mesylate) Capsules 7.5 mg\nAll subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                        "title": "Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "24", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "24", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "sbhaskar@noven.com", 
                "name_or_title": "Sailaja Bhaskar, Executive Director, Clinical Research", 
                "organization": "Noven Therapeutics, LLC", 
                "phone": "(212) 287-0798"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Brisdelle (paroxetine mesylate) Capsules\nAll subjects will receive Brisdelle (paroxetine mesylate) capsules, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
                        "title": "Brisdelle (Paroxetine Mesylate) Capsules"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "23", 
                                            "@subjects_at_risk": "24"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "24"
                                            }, 
                                            "sub_title": "Abdominal pain"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "6", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "24"
                                            }, 
                                            "sub_title": "Constipation"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "24"
                                            }, 
                                            "sub_title": "Diarrhoea"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "6", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "6", 
                                            "@subjects_at_risk": "24"
                                        }, 
                                        "sub_title": "Fatigue"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "3", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "3", 
                                            "@subjects_at_risk": "24"
                                        }, 
                                        "sub_title": "Back pain"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "7", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "24"
                                        }, 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "24"
                                            }, 
                                            "sub_title": "Abnormal dreams"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "24"
                                            }, 
                                            "sub_title": "Insomnia"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "3", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "3", 
                                            "@subjects_at_risk": "24"
                                        }, 
                                        "sub_title": "Hyperhidrosis"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 11.1", 
                    "frequency_threshold": "0"
                }, 
                "time_frame": "21 days"
            }
        }, 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": "Postmenopausal Symptoms", 
        "detailed_description": {
            "textblock": "This study is for research only and is not designed to treat a medical condition."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects who are healthy postmenopausal, non-smoking women of any race and \u226540 years of\n        age at screening.\n\n        Exclusion Criteria:\n\n        Subjects who have a recent history or presence of glaucoma, migraines, cardiovascular,\n        hepato-biliary, renal, gastrointestinal, neurologic, psychiatric, dermatologic, pulmonary,\n        cerebrovascular, endocrine, hematologic, thromboembolic, immunologic disease or any other\n        disorder which requires physician care; subjects who have existing medical conditions\n        which might interfere with absorption, distribution, metabolism, or excretion of study\n        medication; history of self-injurious behavior; history of clinical diagnosis of\n        depression; or treatment for depression; history of clinical diagnosis of border-line\n        personality disorder; presence of any of the following psychiatric disorders within the\n        timeframes specified:  Major Depressive Disorder-Lifetime; Dysthymia-Past 2 Years; Bipolar\n        Disorder-Lifetime; Panic Disorder-Lifetime; Agoraphobia-Past Month; Social Phobia-Past\n        Month; Obsessive Compulsive Disorder-Past Month; Generalized Anxiety-Lifetime; Psychotic\n        Disorders-Lifetime; Anorexia Nervosa-Past 10 Years; Bulimia-Past 10 Years;\n        Suicidality/Suicide Ideation-Lifetime; Post Traumatic Stress Disorder-Lifetime.\n\n        Subjects with a history of seizures; sitting blood pressure (BP) < 90/50 or > 150/90 mmHg;\n        sitting heart rate (HR) < 45 or > 90 beats/min; clinical laboratory test results outside\n        of the normal range for the laboratory conducting the test; positive urine pregnancy test\n        at Screening or Day 0; subjects who have a history of sensitivity to active and/or\n        inactive ingredients in Brisdelle (paroxetine mesylate) Capsules 7.5 mg; subjects who have\n        a history of significant allergies; subjects who have a present or past history of\n        narcotic addiction, drug abuse, or alcoholism; subjects who have smoked or used tobacco\n        during the last 6 months; subjects who have donated one or more pints of blood within 30\n        days prior to treatment administration; subjects who have symptoms of any significant\n        acute illnesses at the screening visit; subjects who used any investigational drug within\n        30 days prior to treatment administration; subjects who took any substances known to be\n        Cytochrome P450 2D6 (CYP2D6) inhibitors within 14 days of study start and throughout the\n        entire study; subjects who used any prescription medications within 14 days of the\n        screening visit; subjects who used St John's Wort within 14 days of the screening visit;\n        subjects who used any over the counter preparations including herbal or nutritional\n        supplements and multivitamins within 10 days prior to receiving the first study treatment;\n        subjects who have consumed foods or beverages containing caffeine/xanthine or alcohol;\n        subjects who have a positive screen for hepatitis B surface antigen (HBsAg) or hepatitis C\n        antibody; subjects who have a positive screen for the Human Immunodeficiency Virus (HIV)\n        antibody; subjects who have a positive urine drug screen; subjects who have any clinically\n        significant illness within 90 days prior to receiving the first dose of study medication."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 9, 2013", 
        "firstreceived_results_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01829919", 
            "org_study_id": "N30-005"
        }, 
        "intervention": {
            "arm_group_label": "Brisdelle (paroxetine mesylate)", 
            "description": "All subjects will receive Brisdelle (paroxetine mesylate) Capsules 7.5 mg, first as a single dose and then, following a five-day wash-out period, once per day for 14 days.", 
            "intervention_name": "Brisdelle (paroxetine mesylate)", 
            "intervention_type": "Drug", 
            "other_name": [
                "Former Names: Mesafem capsules 7.5 mg or", 
                "LDMP (Low-Dose Mesylate salt of Paroxetine)"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Paroxetine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Menopause", 
            "Hot flashes", 
            "Vasomotor symptoms", 
            "Climacteric symptoms", 
            "perimenopause", 
            "Mesafem", 
            "Brisdelle", 
            "Low-Dose Mesylate salt of Paroxetine (LDMP)"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "link": {
            "description": "Sponsor", 
            "url": "http://www.noven.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21201"
                }, 
                "name": "SNBL Clinical Pharmacology Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Pharmacokinetics of Paroxetine Following Single and Repeat Oral Administration of Mesafem (7.5 mg Paroxetine Mesylate) Capsules in Healthy Postmenopausal Women", 
        "overall_official": {
            "last_name": "Mohamed Al-Ibrahim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "AUC (Hour*ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Cmax (ng/mL) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Kel (Hour^-1) Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Mean t1/2 Single Dose Pharmacokinetics of Brisdelle\u2122 (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Median t1/2 Single Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "AUC (Hour*ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "measure": "Cmax (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "measure": "Cmin (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "measure": "Tmax (Hour) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "description": "Accumulation Index is the ratio of AUC 0-24 after multiple doses versus a single dose. It is the increase in drug plasma concentration after multiple dosing until a steady state is reached.  In this case the steady state Accumulation Index was calculated at Day 19. Accumulation Index is calculated at the end of the dosing period.", 
                "measure": "Accumulation Index Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg at Day 19", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "description": "Fluctuation Index is (Cmax-Cmin)/Cavg,ss. It is peak trough fluctuation within one dosing interval at steady state.", 
                "measure": "Fluctuation Index (%) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "measure": "Cavg,ss (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }, 
            {
                "description": "C(t) is the measured plasma level \"Concentration\" of the drug at \"time = t\" expressed as nanograms per milliliter.", 
                "measure": "Ct (ng/mL) Multiple Dose Pharmacokinetics of Brisdelle (Paroxetine Mesylate) Capsules 7.5 mg", 
                "safety_issue": "No", 
                "time_frame": "Day 19"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01829919"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Noven Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Noven Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}